Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

A Phase II Study of Leucovorin, 5-FU and Docetaxel Combination Chemotherapy in Patients with Inoperable or Postoperative Relapsed Gastric Cancer

Kwang-Sun Lee, Ha-Yeon Lee, Eun-Kyung Park, Joung-Soon Jang, Sang-Jae Lee

Cancer Res Treat. 2008;40(1):11-15. Published online March 31, 2008 DOI: https://doi.org/10.4143/crt.2008.40.1.11

Crossref 2

Oxaliplatin, 5-FU, Folinic Acid as First-line Palliative Chemotherapy in Elderly Patients with Metastatic or Recurrent Gastric Cancer

In Sil Choi, Do-Youn Oh, Byoung-Su Kim, Keun-Wook Lee, Jee Hyun Kim, Jong-Seok Lee

Cancer Res Treat. 2007;39(3):99-103. Published online September 30, 2007 DOI: https://doi.org/10.4143/crt.2007.39.3.99

Crossref 19

Phase II Study of Docetaxel and Cisplatin as First-line Chemotherapy in Patients with Recurrent or Metastatic Gastric Cance

Kyung-Ha Kim, Ki-Ju Jeung, Hyun-Jung Kim, Sang-Byung Bae, Chan-Kyu Kim, Nam-Su Lee, Kyu-Taek Lee, Sung-Kyu Park, Jong-Ho Won, Dae-Sik Hong, Hee-Sook Park

Cancer Res Treat. 2007;39(2):49-53. Published online June 30, 2007 DOI: https://doi.org/10.4143/crt.2007.39.2.49

Crossref 4

Long-term Survival after Surgical Resection for Liver Metastasis from Gastric Cancer: Two Case Reports

Jong Keun Lim, Joong Bae Ahn, Sung Ha Cheon, Hyun Chang, Jong Yul Jung, Sun Young Rha, Jae Kyung Roh, Sung Hoon Noh, Ho Geun Kim, Hyun Cheol Chung, Hei-Cheul Jeung

Cancer Res Treat. 2006;38(3):184-188. Published online June 30, 2006 DOI: https://doi.org/10.4143/crt.2006.38.3.184

Crossref 1

The Synergism between Belotecan and Cisplatin in Gastric Cancer

Joo Young Jung, Sang Hyun Song, Tae-Young Kim, Jung Hyun Park, Hyun-Soon Jong, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang, Noe Kyoung Kim

Cancer Res Treat. 2006;38(3):159-167. Published online June 30, 2006 DOI: https://doi.org/10.4143/crt.2006.38.3.159

Crossref 7

A Pilot Study of Cisplatin, Irinotecan, Leucovorin and 5-fluorouracil (PILF) Combination Chemotherapy for Advanced Gastric Cancer

Se Hoon Park, Soo Yeon Jeon, Kwang Il Ko, Eunmi Nam, Soo-Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee, Woon Ki Lee, Min Chung

Cancer Res Treat. 2006;38(3):121-125. Published online June 30, 2006 DOI: https://doi.org/10.4143/crt.2006.38.3.121

Crossref 1

Characteristics of Synchronous Cancers in Gastric Cancer Patients

Ja Seong Bae, Jun Ho Lee, Keun Won Ryu, Young Woo Kim, Jae Moon Bae

Cancer Res Treat. 2006;38(1):25-29. Published online February 28, 2006 DOI: https://doi.org/10.4143/crt.2006.38.1.25

Crossref 19

Increased ERCC Expression Correlates with Improved Outcome of Patients Treated with Cisplatin as an Adjuvant Therapy for Curatively Resected Gastric Cancer

Sun Kyung Baek, Si-Young Kim, Jae Jin Lee, Yoon Wha Kim, Hwi Joong Yoon, Kyung Sam Cho

Cancer Res Treat. 2006;38(1):19-24. Published online February 28, 2006 DOI: https://doi.org/10.4143/crt.2006.38.1.19

Crossref 17

Prognostic Factors for Advanced Gastric Cancer: Stage-stratified Analysis of Patients who Underwent Curative Resection

Joong-Min Park, Woo-Sang Ryu, Jong-Han Kim, Sung-Soo Park, Seung-Joo Kim, Chong-Suk Kim, Young-Jae Mok

Cancer Res Treat. 2006;38(1):13-18. Published online February 28, 2006 DOI: https://doi.org/10.4143/crt.2006.38.1.13

Crossref 26

Long Term Trends and the Future Gastric Cancer Mortality in Korea: 1983~2013

Yunhee Choi, Jin Gwack, Yeonju Kim, Jisuk Bae, Jae-Kwan Jun, Kwang-Pil Ko, Keun-Young Yoo

Cancer Res Treat. 2006;38(1):7-12. Published online February 28, 2006 DOI: https://doi.org/10.4143/crt.2006.38.1.7

Crossref 16

A Multi-Center, Phase II Clinical Trial of Padexol™ (Paclitaxel) and Cisplatin for Patients Suffering with Advanced Gastric Cancer

Min Kyoung Kim, Kyung Hee Lee, Myung Soo Hyun, Young Rok Do, Hong Suk Song, Won Sik Lee, Keon Uk Park, Jin Ho Baek, Jong Gwang Kim

Cancer Res Treat. 2005;37(6):349-353. Published online December 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.6.349

Crossref 8

Oxaliplatin with Biweekly Low Dose Leucovorin and Bolus and Continuous Infusion of 5-fluorouracil (Modified FOLFOX 4) as a Salvage Therapy for Patients with Advanced Gastric Cancer

Sung-Hwan Suh, Hyuk-Chan Kwon, Ji-Hoon Jo, Young-Rak Cho, Bong-Gun Seo, Dong-Mee Lee, Sung-Hyun Kim, Jae-Seok Kim, Hyo-Jin Kim

Cancer Res Treat. 2005;37(5):279-283. Published online October 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.5.279

Crossref 11

Epstein-Barr Virus in Human Malignancy: A Special Reference to Epstein-Barr Virus associated Gastric Carcinoma

Mee Soo Chang, Woo Ho Kim

Cancer Res Treat. 2005;37(5):257-267. Published online October 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.5.257

Crossref 22

A Phase II Trial of Haptaplatin/5-FU and Leucovorin for Advanced Stomach Cancer

Won Sup Lee, Gyeong-Won Lee, Hwal Woong Kim, Ok-Jae Lee, Young-Joon Lee, Gyung Hyuck Ko, Jong-Seok Lee, Joung Soon Jang, Woo Song Ha

Cancer Res Treat. 2005;37(4):208-211. Published online August 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.4.208

Crossref 5

Efficacy and Safety Study of Docetaxel as Salvage Chemotherapy in Metastatic Gastric Cancer Failing Fluoropyrimidine and Platinum Combination Chemotherapy

Jae-Lyun Lee, Min-Hee Ryu, Heung Moon Chang, Tae-Won Kim, Jeong Hwan Yook, Sung Tae Oh, Byung Sik Kim, Jung Shin Lee, Yoon-Koo Kang

Cancer Res Treat. 2005;37(4):201-207. Published online August 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.4.201

Crossref 4

The Surgeon's Expertise-Outcome Relationship in Gastric Cancer Surgery

Wansik Yu, Young Kook Yun, Ilwoo Whang, Gyu Seok Choi

Cancer Res Treat. 2005;37(3):143-147. Published online June 30, 2005 DOI: https://doi.org/10.4143/crt.2005.37.3.143

Crossref 8

Loss of DNA-dependent Protein Kinase Catalytic Subunit (DNA-PKcs) Expression in Gastric Cancers

Hye Seung Lee, Han-Kwang Yang, Woo Ho Kim, Gheeyoung Choe

Cancer Res Treat. 2005;37(2):98-102. Published online April 30, 2005 DOI: https://doi.org/10.4143/crt.2005.37.2.98

Crossref 21

Clinicopathological Analysis of Borrmann Type IV Gastric Cancer

Jeong Hwan Yook, Sung Tae Oh, Byung Sik Kim

Cancer Res Treat. 2005;37(2):87-91. Published online April 30, 2005 DOI: https://doi.org/10.4143/crt.2005.37.2.87

Crossref 26

Chemotherapy for Advanced Gastric Cancer: Slow but Further Progress

Yeul Hong Kim

Cancer Res Treat. 2005;37(2):79-86. Published online April 30, 2005 DOI: https://doi.org/10.4143/crt.2005.37.2.79

Crossref 14

cDNA Microarray Analysis of Differential Gene Expression in Gastric Cancer Cells Sensitive and Resistant to 5-Fluorouracil and Cisplatin

Myung-Ju Ahn, Young-Do Yoo, Ki-Hwan Lee, Joon-Ik Ahn, Dong-Hyun Yu, Hye-Sook Lee, Ho-Suck Oh, Jung-Hye Choi, Yong-Sung Lee

Cancer Res Treat. 2005;37(1):54-62. Published online February 28, 2005 DOI: https://doi.org/10.4143/crt.2005.37.1.54

Crossref 3

The Efficacy of Docetaxel and Cisplatin Combination Chemotherapy for the Treatment of Advanced Gastric Cancer after Failing to 5-Fluorouracil Based Chemotherapy

Sang-Joon Shin, Min-Kyoung Kim, Kyung-Hee Lee, Myung-Soo Hyun, Sang Woon Kim, Sun Kyo Song, Sung-Hwa Bae, Hun-Mo Ryoo

Cancer Res Treat. 2004;36(6):367-371. Published online December 31, 2004 DOI: https://doi.org/10.4143/crt.2004.36.6.367

Crossref 5

Prognostic Significance of CD24 Expression in Gastric Carcinoma

Nevine S. Darwish, Min A Kim, Mee Soo Chang, Hye Seung Lee, Byung Lan Lee, Yong Il Kim, Woo Ho Kim

Cancer Res Treat. 2004;36(5):298-302. Published online October 30, 2004 DOI: https://doi.org/10.4143/crt.2004.36.5.298

Crossref 24

Predictive Value of Preoperative Serum CEA, CA19-9 and CA125 Levels for Peritoneal Metastasis in Patients with Gastric Carcinoma

Gun Ick Hwang, Chang Hak Yoo, Byung Ho Sohn, Jun Ho Shin, Yong Lai Park, Heung Dai Kim, Yong Shin Kim, Won Kon Han, Won Kil Pae

Cancer Res Treat. 2004;36(3):178-181. Published online June 30, 2004 DOI: https://doi.org/10.4143/crt.2004.36.3.178

Crossref 38

Randomized Phase III Trial of Cisplatin, Epirubicin, Leucovorin, 5-Fluorouracil (PELF) Combination versus 5-fluorouracil Alone as Adjuvant Chemotherapy in Curative Resected Stage III Gastric Cancer

Jae Jin Lee, Si-Young Kim, Im sik Shin, Kyung Sam Cho, Hoong-Zae Joo, Choong Yoon, Yoon Wha Kim, Hwi Joong Yoon

Cancer Res Treat. 2004;36(2):140-145. Published online April 30, 2004 DOI: https://doi.org/10.4143/crt.2004.36.2.140

Crossref 7

Synthetic CDCA Derivatives-Induced Apoptosis of Stomach Cancer Cell Line SNU-1 Cells

Bongkyung Moon, Min-Chan Kim, Joo-sung Park

Cancer Res Treat. 2004;36(2):132-139. Published online April 30, 2004 DOI: https://doi.org/10.4143/crt.2004.36.2.132

Crossref 6

Long-term Results of Proximal and Total Gastrectomy for Adenocarcinoma of the Upper Third of the Stomach

Chang Hak Yoo, Byung Ho Sohn, Won Kon Han, Won Kil Pae

Cancer Res Treat. 2004;36(1):50-55. Published online February 29, 2004 DOI: https://doi.org/10.4143/crt.2004.36.1.50

Crossref 57

Telomerase Activity in Gastric Adenocarcinomas: Frozen Tissues Versus Methacarn-fixed Paraffin-embedded Tissues

Jinyoung Yoo, Seok Jin Kang, Chang Suk Kang

Cancer Res Treat. 2003;35(6):478-482. Published online December 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.6.478

Stomach Cancer Incidence, Mortality and Survival Rate in Korean Elderly Pharmacoepidemiologic Cohort (KEPEC) in 1994~1998

Nam Kyong Choi, Kyung Eun Youn, Dae Seuk Heo, Seung Mi Lee, Yooni Kim, Byung Joo Park

Cancer Res Treat. 2003;35(5):383-390. Published online October 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.5.383

Crossref 4

Clinical Significance of the Levels of Serum Cholesterol in Patients with Gastric Cancer

Tae Hyo Kim, Sung Jin Ahn, Woon Tae Jung, Ok Jae Lee, Woo Song Ha, Joung Soon Jang

Cancer Res Treat. 2003;35(4):335-340. Published online August 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.4.335

Crossref 3

Clinical Pharmacokinetics of Tegafur Administered with Epirubicin and Cisplatin in Patients with Advanced Gastric Cancer

Jin Hyung Kang, Yoo Lim Kim, Hea Kyoung Cho, Eun Sook Lee, Soo Jin Cha, Young Sun Hong, Kyung Shik Lee, Hyo Jeong Kuh

Cancer Res Treat. 2003;35(3):224-231. Published online June 30, 2003 DOI: https://doi.org/10.4143/crt.2003.35.3.224